HPV 16 E7:86-93 peptide vaccine
Term · Oncology and biomedicine · MLC-T-ONC-014176
A synthetic peptide vaccine consisting of amino acids 86 through 93 (TLGIVCPI) of the viral oncoprotein human papillomavirus (HPV) 16 E7. Vaccination with HPV-16 E7:86-93 peptide, which binds to HLA-A* 0201 molecule, may stimulate the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells positive for HPV-16 E7.
| Identifier | MLC-T-ONC-014176 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | E7(86-93) |
| Synonyms | E7(86-93) lipopeptide; HPV-16E7 (86-93); HPV 16E7 86-93 Lipopeptide Vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014176",
"term": "HPV 16 E7:86-93 peptide vaccine",
"field": "Oncology and biomedicine",
"definition": "A synthetic peptide vaccine consisting of amino acids 86 through 93 (TLGIVCPI) of the viral oncoprotein human papillomavirus (HPV) 16 E7. Vaccination with HPV-16 E7:86-93 peptide, which binds to HLA-A* 0201 molecule, may stimulate the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells positive for HPV-16 E7.",
"abbreviation": "E7(86-93)",
"synonyms": [
"E7(86-93) lipopeptide",
"HPV-16E7 (86-93)",
"HPV 16E7 86-93 Lipopeptide Vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/hpv-16-e7-86-93-peptide-vaccine/"
}
Record 8,646 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.